Le Lézard
Classified in: Health
Subjects: PDT, BFA

ExtriCARE USA Highlights Mission and Product Innovations in NPWT


PHILADELPHIA, Feb. 22, 2024 /PRNewswire/ -- ExtriCARE USA, an innovator in the Negative Pressure Wound Therapy (NPWT) industry, is proud to present pivotal updates for 2024, showcasing significant advancements in its ExtriCARE product line and the broader NPWT market. A newly released video, featuring President and CEO Peter Mason, delves into these updates, offering valuable insights into ExtriCARE's ongoing commitment to innovation and support for healthcare professionals and patients.

In this video, Peter Mason articulates the evolving landscape of wound care, underscoring the crucial role of technology and innovation in addressing current challenges. He presents ExtriCARE's latest contributions to NPWT, emphasizing the enhancements made to the ExtriCARE product line. "Our mission is to enhance the quality of life for patients with advanced wound care solutions," Mason remarks, also highlighting the support system in place for distribution partners to ensure product availability and exceptional customer service.

This engaging video is a call to action for healthcare professionals, patients, and industry stakeholders to explore ExtriCARE's offerings and understand the impact of these innovations on patient care. The video is accessible on ExtriCARE's YouTube channel, LinkedIn page, and website (www.extricareusa.com).

ExtriCARE USA invites the industry to view the video and join in their mission to advance wound care. For detailed information about ExtriCARE USA and the ExtriCARE product line, please visit www.extriCAREusa.com or call 877.312.NPWT (6798).

About ExtriCARE USA

ExtriCARE USA stands at the forefront of NPWT technology, offering innovative wound care solutions that improve patient outcomes and wound care delivery. The company is committed to quality, innovation, and service, providing a comprehensive range of NPWT products to meet the varied needs of wound care professionals and patients across the globe.

Media Contact:

ExtriCARE USA
877.312.NPWT(6798)
[email protected]

SOURCE ExtriCARE USA


These press releases may also interest you

at 21:03
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, Named Nonprofit Executive of the Year by Los Angeles Business Journal
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:35
InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 19:56
Rare Cannabinoid Company Launches Dispensary-Strength CBG + CBD + THC Rapid Relief Gel With Free Sample Offer
Rare Cannabinoid Company is proud to announce the launch of its new,...

at 18:58
Children's Health and UT Southwestern Receive $100 Million Donation from the Pogue Family for New $5 Billion Dallas Pediatric Campus
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...

More news about Health...


News published on and distributed by: